Loading clinical trials...
Loading clinical trials...
A Phase I/II Trial of Bevacizumab (Avastin), Erlotinib (Tarceva), and Imatinib (Gleevec) in the Treatment of Patients With Advanced Renal Cell Carcinoma
Conditions
Interventions
Bevacizumab
Erlotinib
+1 more
Start Date
June 1, 2004
Primary Completion Date
January 1, 2011
Completion Date
August 1, 2011
Last Updated
January 31, 2013
NCT06349642
NCT07300241
NCT05433142
NCT07227415
NCT06242470
NCT07187778
Lead Sponsor
SCRI Development Innovations, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions